Betz, U.; Goldhofer, M.; Klonschinski, T. et al.
A PROTOCOL FOR HIP AND KNEE REPLACEMENT ACCORDING TO THE PRINCIPLES OF THE ERAS SOCIETYClinical Nutrition ESPEN. Bd. 25. 2018 S. 201
Mueller, V.; Park-Simon, T. -W.; Huober, J. et al.
A randomized, double-blinded pivotal study of tucatinib (ONT-380) vs. placebo in combination with capecitabine and trastuzumab in patients with pretreated HER2-pos. unresectable locally advanced or metastatic breast cancer: HER2CLIMBONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 28-28
Abou-Alfa, Ghassan K.; Chan, Stephen Lam; Furuse, Junji et al.
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Morton, C. A.; Dominicus, R.; Radny, P. et al.
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyBRITISH JOURNAL OF DERMATOLOGY. Bd. 179. H. 2. 2018 S. 309-319
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multi-center phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy-based treatment strategy in patients with hormone receptor-positive, HER2-negative metastatic breast cancer in a real world setting (PADMA)CANCER RESEARCH. Bd. 78. H. 4. 2018
Heimes, Anne-S.; Jaekel, J.; Weyer-Elberich, V. et al.
A retrospective analysis of immunohistochemically determined IRF4 expression in a consecutive cohort of 114 ovarian cancer patientsONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 92-92
Schweiger, Martin; Zuckermann, Andreas; Beiras-Fernandez, Andres et al.
A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant RecipientsANNALS OF TRANSPLANTATION. Bd. 23. 2018 S. 322-333
Zhu, Andrew X.; Galle, Peter R.; Kudo, Masatoshi et al.
A study of ramucirumab (LY3009806) versus placebo in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein (REACH-2).JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 4. 2018
Schoretsanitis, Georgios; Spina, Edoardo; Hiemke, Christoph et al.
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidoneEXPERT REVIEW OF CLINICAL PHARMACOLOGY. Bd. 11. H. 12. 2018 S. 1237-1253
Schoretsanitis, Georgios; Spina, Edoardo; Hiemke, Christoph et al.
A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidoneEXPERT REVIEW OF CLINICAL PHARMACOLOGY. Bd. 11. H. 6. 2018 S. 625-639